Abstract
Background
Atherothrombotic ischemia is the most frequent cause of cerebral ischemia; however, few reports have addressed the prognostic factors predicting early neurological deterioration (END) when the occlusive lesion is limited to the anterior main trunk, middle cerebral artery (MCA) or internal cerebral artery (ICA).
Method
Between 2006 and 2008, 122 atherothrombotic ischemia patients were diagnosed with MCA or ICA occlusive disease on magnetic resonance angiography. The National Institutes of Health Stroke Scale (NIHSS) score and the modified Alberta Stroke Program Early CT Score on diffusion-weighted imaging [ASPECTS-DW (modified)] were calculated. Clinical-DWI mismatch (CDM) was evaluated using NIHSS and the ASPECTS-DW (modified) to examine the predictive efficacy for early neurological deterioration.
Results
Eighteen of 122 (14.8%) patients fulfilled the definition of CDM. END was observed in 24 patients (19.7%) within 15 days after admission. CDM was observed in 14 cases in the END (+) group (14 of 24 cases, 58.3%) and 4 cases in the END (−) group (4 of 98 cases, 4.1%) (p = 0.001). Multivariate logistic regression analysis demonstrated that CDM was a significant predictive factor of END (odds ratio 26.68, p = 0.0001).
Conclusions
CDM based on NIHSS and ASPECTS-DW (modified) could be a significant predictive factor for END of atherothrombotic ischemia in MCA/ICA.
Similar content being viewed by others
References
Arenillas JF, Alvarez-Sabin J, Molina CA, Chacon P, Montaner J, Rovira A, Ibarra B, Quntana M (2003) C-reactive protein predicts further ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke 34:2463–2470
Astrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia: the ischemic penumbra. Stroke 12:723–725
Barber PA, Demchuk AM, Zhang J, Buchan AM, for the ASPECTS Study Group (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombotic therapy. Lancet 355:1670–1674
Darby DG, Barber PA, Gerraty RP, Desmond PM, Yang Q, Parsons M, Li T, Tress BM, Davis SM (1999) Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. Stroke 30:2043–2052
Davalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, Silva Y, Serena J, Castillo J (2004) The clinical-DWI mismatch. A new diagnostic approach to the brain tissue at risk of infarction. Neurology 62:2187–2192
DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ (1999) Progression in acute stroke: value of the initial NIH Stroke Scale score on patient stratification in future trials. Stroke 30:1208–1212
Deguchi I, Takeda H, Furuya D, Hattori K, Dembo T, Nagoya H, Kato Y, Fukuoka T, Maruyama H, Tanahashi N (2011) Significance of clinical diffusion mismatch in hyperacute cerebral infarction. J Stroke Cerebrovasc Dis 20:62–70
Gorelick PB, Wong KS, Bae HJ, Pandey DK (2008) Large artery intracranial occlusive disease. A large worldwide burden but a relative neglected frontier. Stroke 39:2396–2399
Hill MD, Rowley HA, Adler F, Elasziw M, Furlan A, Higashida RT, Wechsler LR, Roberts HC, Dillon WP, Fischbein NJ, Firszt CM, Schulz GA, Buchan AM, for the PROACT-II Investigators (2003) Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 34:1925–1931
Hillis AE, Wityk RJ, Barker PB, Ulatowski JA, Jacobs MA (2003) Changes in perfusion in acute nondominant hemisphere stroke may be better estimated by tests of hemispatial neglect than by the National Institutes of Health Stroke Scale. Stroke 34:2392–2398
Hirai T, Sasaki M, Maeda M, Ida M, Katsuragawa S, Sakoh M, Takano K, Arai S, Hirano T, Kai Y, Kakeda S, Murakami R, Ikeda R, Fukuoka H, Sasano A, Yamashita Y (2009) Acute Stroke Imaging Standardization Group-Japan (ASIST-Japan) investigators. Acad Radiol 16:305–312
Prosser J, Butcher K, Allport L, Parsons M, MacGregor L, Desmond P, Tress B, Davis S (2006) Clinical-diffusion mismatch predicts the putative penumbra with high specificity. Stroke 36:1700–1704
Sasaki M, Yamada K, Watanabe Y, Matsui M, Ida M, Fujiwara S, Shibata E, Acute Stroke Imaging Standardization Group-Japan (ASIST-Japan) (2008) Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multiinstitutional comparison study. Radiology 249:624–630
Sobesky J, Weber OZ, Lehnhardt FG, Hesselmann V, Neveling M, Jacobs A, Heiss WD, Does the mismatch match the penumbra? (2005) Magnetic resonance imaging and position emission tomography in early ischemic stroke. Stroke 36:980–985
Tei H, Uchiyama S, Usui T (2007) Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation. J Neurol 254:340–346
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1588
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (2000) Effects of intravenous recombinant tissue plasminogen activator on ischemic lesion size measured by computed tomography. Stroke 31:2912–2919
The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group (1998) Prognosis of patients with symptomatic vertebral or basilar artery stenosis. Stroke 29:1389–1392
Acknowledgments
The authors thank the radiological technicians at Kohnan Hospital for the preparation of image analysis.
Disclosure
Our present study was approved by the ethics committee of Kohnan Hospital and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Comment
The prognosis and management of stroke patients who could potentially undergo aggressive interventions remain complicated in this difficult to classify subpopulation. In this study, Dr. Saito et al. attempt to correlate the modified Clinical Diffusion Mismatch (CDM) with Early Neurological Deterioration (END) in atherothrombotic disease in patients with anterior circulation lesions. They evaluated 122 patients during a 2-year period using NIHSS and the modified ASPECTS-DW. According to their results, CDM was a significant predictive factor for END.
This group attempted to select a homogenous patient population to determine the efficacy of CDM on a specific population. They were successful in this goal; however, by selecting patients in this manner, the sample size was affected. Logical guidelines in terms of inclusion and exclusion criteria were included.
An interesting post-hoc evaluation would be if the excluded factors for END, such as brain edema, hemorrhagic infarction, etc., were in fact included. This may provide information as to what effect natural history or interventions had on the data.
The current literature suggests the utility of CDM as it accounts for both the clinical status of the patient and the radiological data of tissue perfusion. Utilizing these two separate but essential tools may show promise in determining indications for intervention as well as prognosis for these patients as shown by the multivariate analysis in this study.
Pulak Ray
Christopher M. Loftus
Philadelphia, PA
Rights and permissions
About this article
Cite this article
Saito, A., Shimizu, H., Fujimura, M. et al. Predictive role of modified clinical diffusion mismatch in early neurological deterioration due to atherothrombotic ischemia in the anterior circulation. Acta Neurochir 153, 2205–2210 (2011). https://doi.org/10.1007/s00701-011-1084-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-011-1084-4